ibandronic acid has been researched along with Joint Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelt, KA; Meier, C; Müller, F; Suhm, N | 1 |
| Sittig, HB | 1 |
1 review(s) available for ibandronic acid and Joint Pain
| Article | Year |
|---|---|
Pathogenesis and bisphosphonate treatment of skeletal events and bone pain in metastatic cancer: focus on ibandronate.
Topics: Arthralgia; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Ibandronic Acid | 2012 |
1 other study(ies) available for ibandronic acid and Joint Pain
| Article | Year |
|---|---|
Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
Topics: Aged; Arthralgia; Biomarkers; Bone Density Conservation Agents; Bone Marrow Diseases; Collagen Type I; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Retrospective Studies; Vitamin D; Zoledronic Acid | 2020 |